blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3316876

EP3316876 - ARGININE SILICATE INOSITOL FOR IMPROVING COGNITIVE FUNCTION [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  15.01.2021
Database last updated on 18.05.2024
FormerThe patent has been granted
Status updated on  07.02.2020
FormerGrant of patent is intended
Status updated on  12.09.2019
FormerRequest for examination was made
Status updated on  30.07.2019
FormerGrant of patent is intended
Status updated on  25.03.2019
FormerRequest for examination was made
Status updated on  06.04.2018
FormerThe international publication has been made
Status updated on  06.01.2017
Most recent event   Tooltip08.07.2022Lapse of the patent in a contracting state
New state(s): AL, MK		published on 10.08.2022  [2022/32]
Applicant(s)For all designated states
Nutrition 21, LLC
500 Mamaroneck Ave.
Suite 510
Harrison, NY 10528 / US
[N/P]
Former [2020/10]For all designated states
Nutrition 21, LLC
1 Manhattanville Road
Suite 104
Purchase, NY 10577 / US
Former [2018/19]For all designated states
JDS Therapeutics, LLC
1 Manhattanville Road, Suite 104
Purchase, NY 10577 / US
Inventor(s)01 / KOMOROWSKI, James, R.
83 Bunker Hill Drive
Trumbull, CT 06611 / US
 [2018/19]
Representative(s)Hamer, Christopher K., et al
Mathys & Squire The Shard
32 London Bridge Street
London SE1 9SG / GB
[N/P]
Former [2018/19]Hamer, Christopher K., et al
Mathys & Squire LLP The Shard
32 London Bridge Street
London SE1 9SG / GB
Application number, filing date16739338.829.06.2016
[2018/19]
WO2016US40128
Priority number, dateUS201562187120P30.06.2015         Original published format: US 201562187120 P
[2018/19]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2017004226
Date:05.01.2017
Language:EN
[2017/01]
Type: A1 Application with search report 
No.:EP3316876
Date:09.05.2018
Language:EN
The application published by WIPO in one of the EPO official languages on 05.01.2017 takes the place of the publication of the European patent application.
[2018/19]
Type: B1 Patent specification 
No.:EP3316876
Date:11.03.2020
Language:EN
[2020/11]
Search report(s)International search report - published on:EP05.01.2017
ClassificationIPC:A61K31/047, A61K31/198, A61K31/695, A61P25/28
[2018/19]
CPC:
A61K31/695 (EP,GB,US); A61K31/047 (EP,GB,US); A61B5/16 (GB);
A61B5/4088 (GB,US); A61K31/198 (EP,GB,US); A61K31/445 (EP,GB,US);
A61K33/24 (EP,GB,US); A61K35/24 (GB); A61K47/10 (US);
A61K9/0053 (GB,US); A61K9/0095 (GB,US); A61P25/28 (EP,GB);
A61K2300/00 (GB) (-)
C-Set:
A61K31/047, A61K2300/00 (US,EP);
A61K31/198, A61K2300/00 (EP,US);
A61K31/695, A61K2300/00 (US,EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/19]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:ARGININ-SILICAT-INOSITOL ZUR VERBESSERUNG DER KOGNITIVEN FUNKTION[2018/19]
English:ARGININE SILICATE INOSITOL FOR IMPROVING COGNITIVE FUNCTION[2018/19]
French:ARGININE-SILICATE-INOSITOL POUR AMÉLIORATION DE LA FONCTION COGNITIVE[2018/19]
Entry into regional phase05.01.2018National basic fee paid 
05.01.2018Designation fee(s) paid 
05.01.2018Examination fee paid 
Examination procedure05.01.2018Examination requested  [2018/19]
05.01.2018Date on which the examining division has become responsible
29.06.2018Amendment by applicant (claims and/or description)
26.03.2019Communication of intention to grant the patent
25.07.2019Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
13.09.2019Communication of intention to grant the patent
06.01.2020Fee for grant paid
06.01.2020Fee for publishing/printing paid
06.01.2020Receipt of the translation of the claim(s)
Divisional application(s)EP20159628.5  / EP3721876
Opposition(s)14.12.2020No opposition filed within time limit [2021/07]
Fees paidRenewal fee
27.06.2018Renewal fee patent year 03
27.06.2019Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU29.06.2016
AL11.03.2020
AT11.03.2020
CY11.03.2020
DK11.03.2020
EE11.03.2020
FI11.03.2020
HR11.03.2020
IT11.03.2020
LT11.03.2020
LV11.03.2020
MC11.03.2020
MK11.03.2020
MT11.03.2020
RO11.03.2020
RS11.03.2020
SE11.03.2020
SI11.03.2020
SM11.03.2020
TR11.03.2020
BG11.06.2020
NO11.06.2020
GR12.06.2020
LU29.06.2020
BE30.06.2020
IS11.07.2020
PT05.08.2020
[2022/31]
Former [2022/27]HU29.06.2016
AT11.03.2020
CY11.03.2020
DK11.03.2020
EE11.03.2020
FI11.03.2020
HR11.03.2020
IT11.03.2020
LT11.03.2020
LV11.03.2020
MC11.03.2020
MT11.03.2020
RO11.03.2020
RS11.03.2020
SE11.03.2020
SI11.03.2020
SM11.03.2020
TR11.03.2020
BG11.06.2020
NO11.06.2020
GR12.06.2020
LU29.06.2020
BE30.06.2020
IS11.07.2020
PT05.08.2020
Former [2021/24]AT11.03.2020
DK11.03.2020
EE11.03.2020
FI11.03.2020
HR11.03.2020
IT11.03.2020
LT11.03.2020
LV11.03.2020
MC11.03.2020
RO11.03.2020
RS11.03.2020
SE11.03.2020
SI11.03.2020
SM11.03.2020
BG11.06.2020
NO11.06.2020
GR12.06.2020
LU29.06.2020
BE30.06.2020
IS11.07.2020
PT05.08.2020
Former [2021/15]AT11.03.2020
DK11.03.2020
EE11.03.2020
FI11.03.2020
HR11.03.2020
IT11.03.2020
LT11.03.2020
LV11.03.2020
MC11.03.2020
RO11.03.2020
RS11.03.2020
SE11.03.2020
SI11.03.2020
SM11.03.2020
BG11.06.2020
NO11.06.2020
GR12.06.2020
LU29.06.2020
IS11.07.2020
PT05.08.2020
Former [2021/10]AT11.03.2020
DK11.03.2020
EE11.03.2020
FI11.03.2020
HR11.03.2020
IT11.03.2020
LT11.03.2020
LV11.03.2020
MC11.03.2020
RO11.03.2020
RS11.03.2020
SE11.03.2020
SI11.03.2020
SM11.03.2020
BG11.06.2020
NO11.06.2020
GR12.06.2020
IS11.07.2020
PT05.08.2020
Former [2021/08]DK11.03.2020
EE11.03.2020
FI11.03.2020
HR11.03.2020
LT11.03.2020
LV11.03.2020
RO11.03.2020
RS11.03.2020
SE11.03.2020
SM11.03.2020
BG11.06.2020
NO11.06.2020
GR12.06.2020
IS11.07.2020
PT05.08.2020
Former [2020/50]EE11.03.2020
FI11.03.2020
HR11.03.2020
LT11.03.2020
LV11.03.2020
RO11.03.2020
RS11.03.2020
SE11.03.2020
SM11.03.2020
BG11.06.2020
NO11.06.2020
GR12.06.2020
IS11.07.2020
PT05.08.2020
Former [2020/48]FI11.03.2020
HR11.03.2020
LT11.03.2020
LV11.03.2020
RO11.03.2020
RS11.03.2020
SE11.03.2020
SM11.03.2020
BG11.06.2020
NO11.06.2020
GR12.06.2020
IS11.07.2020
PT05.08.2020
Former [2020/47]FI11.03.2020
HR11.03.2020
LT11.03.2020
LV11.03.2020
RS11.03.2020
SE11.03.2020
BG11.06.2020
NO11.06.2020
GR12.06.2020
IS11.07.2020
Former [2020/46]FI11.03.2020
HR11.03.2020
LV11.03.2020
RS11.03.2020
SE11.03.2020
BG11.06.2020
NO11.06.2020
GR12.06.2020
IS11.07.2020
Former [2020/39]FI11.03.2020
HR11.03.2020
LV11.03.2020
RS11.03.2020
SE11.03.2020
BG11.06.2020
NO11.06.2020
GR12.06.2020
Former [2020/38]FI11.03.2020
HR11.03.2020
LV11.03.2020
RS11.03.2020
SE11.03.2020
NO11.06.2020
GR12.06.2020
Former [2020/37]FI11.03.2020
HR11.03.2020
LV11.03.2020
RS11.03.2020
SE11.03.2020
NO11.06.2020
Former [2020/35]FI11.03.2020
NO11.06.2020
Cited inInternational search[XA]US5707970  (MCCARTY MARK F [US], et al) [X] 20 * claims 1,9 * [A] 1-19;
 [XA]WO2004017913  (NUTRITION 21 INC [US]) [X] 20 * page 11, line 23; claims 19,,20 * * page 29, line 2 * [A] 1-19;
 [A]WO2012173808  (ELAN PHARM INC [US], et al) [A] 1-20* example 1; claim 2 *;
 [A]  - CHERIAN LEELA ET AL, "L-arginine and free radical scavengers increase cerebral blood flow and brain tissue nitric oxide concentrations after controlled cortical impact injury in rats", JOURNAL OF NEUROTRAUMA, M.A. LIEBERT, NEW YORK, NY, US, (20030101), vol. 20, no. 1, doi:10.1089/08977150360517209, ISSN 0897-7151, pages 77 - 85, XP009106134 [A] 1-20 * abstract *

DOI:   http://dx.doi.org/10.1089/08977150360517209
by applicant   - MARSH, D.W.; RICHARD, L.A.; VERRE, A.B.; MYERS, J., "Relationships Among Balance, Visual Search, and Lacrosse-Shot Accuracy", J OF STR & COND RES, (2010), vol. 24, no. 6, pages 1507 - 1514
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.